Mark W. Lingen to Radiotherapy, Intensity-Modulated
This is a "connection" page, showing publications Mark W. Lingen has written about Radiotherapy, Intensity-Modulated.
Connection Strength
0.024
-
A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFeradeā¢ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation. Ann Oncol. 2013 Mar; 24(3):769-76.
Score: 0.024